The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups-Reference-Cited by-同舟云学术

The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups

Published:2003-09-26 Issue:1 Volume:123 Page:81-89
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Oosterveld Margriet,Wittebol Shulamiet H.,Lemmens Wim A. J. G.,Kiemeney Bart A. L. M.,Çatik Ashuman,Muus Petra,Schattenberg Anton V. M. B.,De Witte Theo J. M.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04544.x/fullpdf

Reference24 articles.

1. Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score;Appelbaum;Leukemia,1998

2. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system;Aul;Leukemia,1992

3. The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution;Balduini;Haematologica,1999

4. Proposals for the classification of the myelodysplastic syndromes;Bennett;British Journal of Haematology,1982

5. Cox , D.R. Oakes , D. 1984 Analysis of Survival Data

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leczenie zespołów mielodysplastycznych wysokiego ryzyka u dorosłych wg rekomendacji European LeukemiaNet;Acta Haematologica Polonica;2014-10

2. Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies;Annals of Hematology;2014-08-07

3. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet;Blood;2013-10-24

4. The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Myelodysplastic Syndromes: An Evidence-Based Review;Biology of Blood and Marrow Transplantation;2009-02

5. Myelodysplastic syndrome: An update on diagnosis and therapy;Current Hematologic Malignancy Reports;2008-12-24